The study included a @-week conversion from CL+E or CLE to IPX@ , followed by two @-week , double-blind crossover treatment periods in randomized order , one on IPX@ ( and placebo CL+E ) , the other on CL+E ( and placebo IPX@ ) , separated by @-week open-label IPX@ treatment .